At a glance
ClinicalIndex Comparison RecordN/ACompleted· 20 enrolled
Drug / intervention
S9 Elite with Acclimate +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of Positive Airway Pressure (PAP) Feature to Improve Patient Adherence to Therapy
In Brief
A clinical study evaluating S9 Elite with Acclimate and S9 Elite for Obstructive Sleep Apnea. Completed, enrolled 20 participants across 1 site.
Detailed Summary
The purpose of the study is to evaluate if using the Acclimate feature at the beginning of Positive Airway Pressure (PAP) therapy results in patients using their PAP therapy at least as long as they would standard therapy. Additionally, the Acclimate feature will be evaluated with regard to patient comfort, ease of acceptance of PAP therapy, leak events, and respiratory events.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObstructive Sleep Apnea
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedAug 2011
Enrollment StartSep 2011
Primary CompletionDec 2011
TodayJul 2026
First PostedAug 23, 2011
Enrollment StartSep 1, 2011
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 14.9 years ago
Interventions
S9 Elite with Acclimatedevice
S9 Elite Flow Generator with Acclimate feature activated
S9 Elitedevice
S9 Elite Flow Generator